MRI prognosticators for adverse maternal and neonatal clinical outcome in patients at high risk for placenta accreta spectrum (PAS) disorders

2018 ◽  
Vol 50 (2) ◽  
pp. 602-618 ◽  
Author(s):  
Charis Bourgioti ◽  
Konstantina Zafeiropoulou ◽  
Stavros Fotopoulos ◽  
Maria Evangelia Nikolaidou ◽  
Marianna Theodora ◽  
...  
Keyword(s):  
High Risk ◽  
Clinical Outcome ◽  
Placenta Accreta ◽  
Placenta Accreta Spectrum

Intraplacental Fetal Vessel Diameter May Help Predict for Placental Invasiveness in Pregnant Women at High Risk for Placenta Accreta Spectrum Disorders

Radiology ◽  
2020 ◽  
pp. 200273 ◽  
Author(s):  
Charis Bourgioti ◽  
Anastasia Evangelia Konstantinidou ◽  
Konstantina Zafeiropoulou ◽  
Aristeidis Antoniou ◽  
Stavros Fotopoulos ◽  
...  
Keyword(s):  
High Risk ◽  
Pregnant Women ◽  
Placenta Accreta ◽  
Vessel Diameter ◽  
Placenta Accreta Spectrum ◽  
Spectrum Disorders ◽  
Fetal Vessel

Prenatal planning of placenta previa: diagnostic accuracy of a novel MRI-based prediction model for placenta accreta spectrum (PAS) and clinical outcome

2019 ◽  
Vol 44 (5) ◽  
pp. 1873-1882 ◽  
Author(s):  
Andrea Delli Pizzi ◽  
Alessandra Tavoletta ◽  
Roberta Narciso ◽  
Domenico Mastrodicasa ◽  
Stefano Trebeschi ◽  
...  
Keyword(s):  
Clinical Outcome ◽  
Diagnostic Accuracy ◽  
Prediction Model ◽  
Placenta Accreta ◽  
Placenta Previa ◽  
Placenta Accreta Spectrum

Role of Placenta Accreta Index for Diagnosis of Placenta Accreta Spectrum in High-Risk Patients

2021 ◽  
Author(s):  
Sugandha Bansal ◽  
Jyotsna Suri ◽  
S. K. Bajaj ◽  
Charanjeet Ahluwalia ◽  
Divya Pandey ◽  
...  
Keyword(s):  
High Risk ◽  
Placenta Accreta ◽  
High Risk Patients ◽  
Risk Patients ◽  
Placenta Accreta Spectrum

Placenta Accreta Spectrum: Correlation of MRI Parameters With Pathologic and Surgical Outcomes of High-Risk Pregnancies

2020 ◽  
Vol 214 (6) ◽  
pp. 1417-1423
Author(s):  
Haley R. Clark ◽  
Timothy W. Ng ◽  
Ambereen Khan ◽  
Sarah Happe ◽  
Jodi Dashe ◽  
...  
Keyword(s):  
High Risk ◽  
Surgical Outcomes ◽  
Placenta Accreta ◽  
Placenta Accreta Spectrum ◽  
Spectrum Correlation

scholarly journals OC08.02: Outcomes of pregnancies at high risk for placenta accreta spectrum following negative diagnostic imaging

2020 ◽  
Vol 56 (S1) ◽  
pp. 23-23
Author(s):  
M. Genc ◽  
C. Reeder ◽  
K.R. Sylvester‐Armstrong ◽  
E. Wert ◽  
L. Silva
Keyword(s):  
High Risk ◽  
Diagnostic Imaging ◽  
Placenta Accreta ◽  
Placenta Accreta Spectrum

Significance of the routine first-trimester antenatal screening program for aneuploidy in the assessment of the risk of placenta accreta spectrum disorders

2019 ◽  
Vol 48 (1) ◽  
pp. 21-26
Author(s):  
Grigory A. Penzhoyan ◽  
Tatiana B. Makukhina
Keyword(s):  
High Risk ◽  
Blood Loss ◽  
Pregnant Women ◽  
Placenta Accreta ◽  
Screening Program ◽  
First Trimester ◽  
Significant Difference ◽  
Placenta Accreta Spectrum ◽  
Spectrum Disorders ◽  
Β Hcg

AbstractObjectiveTo select a group at high risk of placenta accreta spectrum disorders (PAS) based on the data of serum screening in the first trimester.MethodsA retrospective analysis of 48 patients with abnormal placental location (AP), including placenta previa (PP) only (n = 23) and PP and PAS (n = 25), was performed. Additionally, the AP group was divided depending on the blood loss volume: not higher than 1000 mL (LBL) (n = 29) and higher than 1000 mL (HBL) (n = 19); diagnostic term of PAS by ultrasound, data pregnancy-associated plasma protein-A (РAРР-A) and free β subunit of human chorionic gonadotropin (free β-hCG) multiple of median (MоM) at 11+0–13+6 weeks of gestation were evaluated. Serological markers were compared with the data of 39 healthy pregnant women with scar after previous cesarean section and normal placental location (control).ResultsThe mean gestation at diagnostic term of PAS was 29 weeks. PAPP-Р MоM [mean (M) ± standard deviation (SD)] was: in controls, 1.07 ± 0.47; in the AP group, 1.59 ± 0.24; in PP, 1.91 ± 1.52; in PAS, 1.30 ± 0.85; in LBL, 1.37 ± 1.20; in HBL, 1.91 ± 1.24. The difference between control/AP, control/PP, control/PAS, PP/PAS, control/LBL, control/HBL and LBL/HBL was Р = 0.256, 0.145, 0.640, 0.311, 0.954, 0.025 and 0.09, respectively. Free β-hCG MoM (M ± SD) was: in controls, 1.08 ± 0.69, in AP, 1.31 ± 0.96; in PP, 1.46 ± 0.19; in PAS, 1.16 ± 0.65; in LBL, 1.30 ± 0.06; in HBL, 1.32 ± 0.78. Comparison of free β-hCG AP with controls and between subgroups did not reveal a significant difference.ConclusionUnderestimation of PAS risk factors in pregnant women with AP leads to late diagnostics of pathology only in the third trimester. The assessment of the РAРР-A level in the first trimester may be helpful for the early prognosis of pathological blood loss at delivery for pregnant women with AP and for forming the high-risk group for PAS.

Complicated placenta accreta spectrum: identifying a high-risk cohort

2021 ◽  
pp. 1-9
Author(s):  
Brian A. Crosland ◽  
Alice M. Sherman-Brown ◽  
Megan C. Oakes ◽  
Laura R. Cuevas ◽  
Andreea I. Dinicu ◽  
...  
Keyword(s):  
High Risk ◽  
Placenta Accreta ◽  
Placenta Accreta Spectrum ◽  
High Risk Cohort
Sign in / Sign up

Export Citation Format

Share Document